Literature DB >> 3074559

Fulminant hepatic failure.

R J Yanda.   

Abstract

These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from transcriptions, they are prepared by Drs Homer A. Boushey, Professor of Medicine, and David G. Warnock, Associate Professor of Medicine, under the direction of Dr Lloyd H. Smith, Jr, Professor of Medicine and Associate Dean in the School of Medicine. Requests for reprints should be sent to the Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143.

Entities:  

Mesh:

Year:  1988        PMID: 3074559      PMCID: PMC1026537     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  39 in total

1.  The liver during and after fulminant hepatitis.

Authors:  J T Horney; J T Galambos
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

Review 2.  The management of fulminant hepatic failure.

Authors:  C Trey; C S Davidson
Journal:  Prog Liver Dis       Date:  1970

3.  Earlier charcoal haemoperfusion in fulminant hepatic failure.

Authors:  A E Gimson; S Braude; P J Mellon; J Canalese; R Williams
Journal:  Lancet       Date:  1982-09-25       Impact factor: 79.321

4.  Letter: Randomization of corticosteroid therapy in fulminant hepatitis.

Authors:  A G Redeker; I L Schweitzer; H S Yamahiro
Journal:  N Engl J Med       Date:  1976-03-25       Impact factor: 91.245

Review 5.  Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features.

Authors:  J L Dienstag
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

6.  Fulminant hepatic failure.

Authors:  N Tygstrup; L Ranek
Journal:  Clin Gastroenterol       Date:  1981-01

7.  Frequency of arrhythmias and other cardiac abnormalities in fulminant hepatic failure.

Authors:  M J Weston; I C Talbot; P J Horoworth; A K Mant; R Capildeo; R Williams
Journal:  Br Heart J       Date:  1976-11

8.  Bacteraemia in patients with fulminant hepatic failure.

Authors:  R J Wyke; J C Canalese; A E Gimson; R Williams
Journal:  Liver       Date:  1982-03

9.  Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

Authors:  J G O'Grady; A E Gimson; C J O'Brien; A Pucknell; R D Hughes; R Williams
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

10.  H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials.

Authors:  B R Macdougall; R J Bailey; R Williams
Journal:  Lancet       Date:  1977-03-19       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.